Recent Articles from MarketBeat

MarketBeat is an American financial media company headquartered in Sioux Falls, South Dakota, founded in 2011 by Matthew Paulson as Analyst Ratings Network before rebranding in 2015. The company operates an online platform that delivers real-time financial data, market analysis, and news, aiming to empower individual investors with tools to make informed trading decisions.

CVRx Eyes Barostim Growth as Coverage Gains and BENEFIT-HF Trial Launchesmarketbeat.com
CVRx (NASDAQ:CVRX) outlined its efforts to expand adoption of its Barostim therapy for heart failure patients, emphasizing sales-force execution, payer coverage progress and a large post-market clinical trial during Canaccord Genuity’s 46th Annual Growth Conference. President and CEO Kevin Hykes sa
Via MarketBeat · August 13, 2026
Antofagasta H1 Earnings Call Highlightsmarketbeat.com
Antofagasta (LON:ANTO) reported higher first-half earnings as stronger realized prices for copper and by-products, productivity gains and cost discipline offset lower copper production. The company said its major growth projects remain on track for completion in 2027 and are expected to increase pro
Via MarketBeat · August 13, 2026
CommVault Systems Sees Cyber Resilience, SaaS Growth Powering Next Expansionmarketbeat.com
CommVault Systems (NASDAQ:CVLT) said the market for data protection has shifted from traditional backup and recovery toward cyber resilience, a trend Chief Financial Officer Gary Merrill said has accelerated over the past three years. Speaking at the KeyBanc Technology Leadership Forum, Merrill sai
Via MarketBeat · August 13, 2026
Castle Biosciences Raises Outlook as Melanoma, TissueCypher Tests Gain Tractionmarketbeat.com
Castle Biosciences (NASDAQ:CSTL) reported continued momentum in its core diagnostic franchises during the second quarter, prompting the company to raise its outlook by more than the amount of its reported beat, according to CFO Frank Stokes. Stokes said the company’s DecisionDx-Melanoma and TissueC
Via MarketBeat · August 13, 2026
Linamar Q2 Earnings Call Highlightsmarketbeat.com
Linamar (TSE:LNR) reported record second-quarter sales of CAD 3.1 billion and normalized net earnings of CAD 183 million, as strong performance in its mobility business and access-equipment operations offset weak agricultural markets and tariff-related pressure in its industrial segment. Normalized
Via MarketBeat · August 13, 2026
BioStem Technologies Q2 Earnings Call Highlightsmarketbeat.com
BioStem Technologies (OTCMKTS:BSEM) reported second-quarter revenue of $7.9 million as the company continued its transition to a predominantly hospital-focused commercial model. Revenue increased from $6.1 million in the first quarter, supported by higher hospital sales, expanded commercial coverage
Via MarketBeat · August 13, 2026
Ascend Wellness Q2 Earnings Call Highlightsmarketbeat.com
Ascend Wellness (OTCMKTS:AAWH) reported second-quarter 2026 net revenue of $126.1 million, up 7.9% sequentially, as new dispensary openings and higher retail sales helped offset pricing pressure and competitive conditions in several markets. Adjusted EBITDA rose 10.5% from the first quarter to $29.
Via MarketBeat · August 13, 2026
AutoCanada Q2 Earnings Call Highlightsmarketbeat.com
AutoCanada (TSE:ACQ) reported higher second-quarter revenue but lower profitability as vehicle margins and fixed operations performance remained under pressure in a soft Canadian auto market. Revenue from continuing operations increased 6% year over year to CAD 1.4 billion, while same-store revenue
Via MarketBeat · August 13, 2026
Stem Q2 Earnings Call Highlightsmarketbeat.com
Stem (NYSE:STEM) reported second-quarter results that highlighted continued profitability progress, higher software and edge-hardware revenue, and expanding utility-scale energy-management-system deployments internationally. The company reaffirmed its full-year 2026 guidance, while management said i
Via MarketBeat · August 13, 2026
STUB Q2 Earnings Call Highlightsmarketbeat.com
StubHub (NYSE:STUB) reported second-quarter results marked by strong growth in gross merchandise sales, revenue and adjusted EBITDA, aided by demand for live events and the World Cup. Management also raised its full-year GMS outlook while maintaining its adjusted EBITDA forecast, citing a discipline
Via MarketBeat · August 13, 2026
Standard Lithium Q2 Earnings Call Highlightsmarketbeat.com
Standard Lithium (NYSEAMERICAN:SLI) said it completed two of four key pre-final investment decision milestones for its Southwest Arkansas lithium project during the second quarter of 2026, while continuing work on customer offtake agreements and project financing. Chief Executive Officer David Park
Via MarketBeat · August 13, 2026
Spire Global Q2 Earnings Call Highlightsmarketbeat.com
Spire Global (NYSE:SPIR) reported second-quarter revenue of $18 million and reaffirmed its 2026 revenue outlook of $75 million to $85 million, as the satellite-data company cited growing government weather, radio frequency geolocation and international defense opportunities. Chief Executive Officer
Via MarketBeat · August 13, 2026
Cirrus Logic Sees Mixed-Signal Growth Pipeline Despite PC and Supply Chain Headwindsmarketbeat.com
Cirrus Logic (NASDAQ:CRUS) executives said the company sees a strong pipeline of opportunities across high-performance mixed-signal products, while continuing to manage supply-chain constraints and delayed platform ramps affecting portions of its smartphone and PC businesses. Speaking at a KeyBanc
Via MarketBeat · August 12, 2026
Infleqtion Q2 Earnings Call Highlightsmarketbeat.com
Infleqtion (NYSE:INFQ) reported record second-quarter 2026 revenue of $12.6 million, up 116% from a year earlier, and raised its full-year revenue outlook to approximately $43 million as the neutral-atom quantum technology company cited stronger bookings visibility and expanding government and comme
Via MarketBeat · August 12, 2026
BTGO Q2 Earnings Call Highlightsmarketbeat.com
BTGO (NYSE:BTGO) reported higher second-quarter revenue and continued growth in assets on its platform, but lower trading margins and an unfavorable revenue mix weighed on profitability as digital asset markets weakened. Co-founder and CEO Mike Belshe said the company expanded normalized assets on
Via MarketBeat · August 12, 2026
Resideo Technologies Q2 Earnings Call Highlightsmarketbeat.com
Resideo Technologies (NYSE:REZI) reported second-quarter 2026 results that exceeded the high end of its outlook ranges, while completing the Aug. 3 spin-off of its ADI Global Distribution business and outlining a standalone outlook for the remainder of the year. Chief Executive Officer Tom Surran,
Via MarketBeat · August 12, 2026
Sky Harbour Group Q2 Earnings Call Highlightsmarketbeat.com
Sky Harbour Group (NYSE:SKYH) reported higher second-quarter revenue and reached positive consolidated operating cash flow, as the private aviation hangar developer and operator continued to expand construction activity, add capacity at existing campuses and pursue larger opportunities at tier-one a
Via MarketBeat · August 12, 2026
Energous Q2 Earnings Call Highlightsmarketbeat.com
Energous (NASDAQ:WATT) reported second-quarter revenue of approximately $3.1 million, up 217% from the prior-year period, as the wireless power company expanded enterprise deployments and progressed proof-of-concept programs across retail, logistics, food service and government markets. For the fir
Via MarketBeat · August 12, 2026
Andersen Group Q2 Earnings Call Highlightsmarketbeat.com
Andersen Group (NYSE:ANDG) reported second-quarter revenue that exceeded its prior outlook, driven by broad-based organic growth across service lines and U.S. regions, while management reaffirmed its full-year revenue and adjusted EBITDA guidance. Revenue for the second quarter totaled $217.7 milli
Via MarketBeat · August 12, 2026
Talphera Q2 Earnings Call Highlightsmarketbeat.com
Talphera (NASDAQ:TLPH) said it had reached 75% enrollment in its NEPHRO-CRRT registrational study and remains on track to complete enrollment later in 2026, as the company prepares for a potential commercial launch of its nafamostat anticoagulant candidate for continuous renal replacement therapy, o
Via MarketBeat · August 12, 2026
Usio Q2 Earnings Call Highlightsmarketbeat.com
Usio (NASDAQ:USIO) reported second-quarter fiscal 2026 revenue growth of 19% and its second consecutive quarter of positive GAAP net income, while raising its full-year revenue growth outlook. Senior Vice President and Chief Accounting Officer Michael White said the company met or exceeded analyst
Via MarketBeat · August 12, 2026
STAAR Surgical Q2 Earnings Call Highlightsmarketbeat.com
STAAR Surgical (NASDAQ:STAA) reported second-quarter 2026 net sales of $93.5 million, up 111% from $44.3 million a year earlier, as growth in China, the Americas and parts of Europe contributed to what President and Chief Executive Officer Warren Foust called the company’s strongest first half of re
Via MarketBeat · August 12, 2026
Cogent Communications Sees AI Traffic Upside, but Infrastructure Bottlenecks Loomcogent-com
Cogent Communications (NASDAQ:CCOI) Chief Executive Officer Dave Schaeffer said the company is positioned to benefit from growing artificial intelligence infrastructure demand through both higher internet traffic and increased demand for optical wavelength services, though he cautioned that deployme
Via MarketBeat · August 12, 2026
Sera Prognostics Q2 Earnings Call Highlightsmarketbeat.com
Sera Prognostics (NASDAQ:SERA) reported modest second-quarter revenue while outlining progress in payer engagement, Illinois Medicaid policy, clinical evidence and European regulatory preparations for its PreTRM Test-guided care platform. Revenue for the quarter ended June 30 was $30,000, compared
Via MarketBeat · August 12, 2026
SKYX Platforms Q2 Earnings Call Highlightsmarketbeat.com
SKYX Platforms (NASDAQ:SKYX) reported record second-quarter revenue of $25.3 million, up 14% sequentially from $22.1 million in the first quarter and 10% from $23 million a year earlier. Management said the result marked its 10th consecutive quarter of year-over-year growth, despite continued declin
Via MarketBeat · August 12, 2026
Spero Therapeutics Q2 Earnings Call Highlightsmarketbeat.com
Spero Therapeutics (NASDAQ:SPRO) used its second-quarter update to outline a strategic shift toward immune-mediated diseases, supported by the FDA approval of Utebzi and a new licensing agreement for SP001, an antibody candidate the company plans to develop initially for IgG4-related disease. Presi
Via MarketBeat · August 12, 2026
comScore Q2 Earnings Call Highlightsmarketbeat.com
comScore (NASDAQ:SCOR) reported second-quarter revenue declines and a sharp reduction in adjusted EBITDA as the media measurement company unveiled a restructuring plan aimed at lowering costs, simplifying operations and concentrating investment on selected growth opportunities. Chief Executive Offi
Via MarketBeat · August 12, 2026
RenovoRx Q2 Earnings Call Highlightsmarketbeat.com
RenovoRx (NASDAQ:RNXT) reported record second-quarter revenue as it expanded its commercial cancer-center network and advanced its clinical program for locally advanced pancreatic cancer. For the quarter ended June 30, 2026, the company generated revenue of $909,000, up approximately 61% from $563,
Via MarketBeat · August 12, 2026
Red Robin Gourmet Burgers Q2 Earnings Call Highlightsmarketbeat.com
Red Robin Gourmet Burgers (NASDAQ:RRGB) reported second-quarter 2026 comparable sales growth and improved restaurant-level margins as the casual-dining chain continued to invest in value offerings, marketing and operational efficiency under its “First Choice” plan. Chief Executive Officer Dave Pace
Via MarketBeat · August 12, 2026
Perma-Fix Environmental Services Q2 Earnings Call Highlightsmarketbeat.com
Perma-Fix Environmental Services (NASDAQ:PESI) reported second-quarter results that fell below management’s expectations, as delayed processing of Hanford-related waste pushed associated revenue into the second half of the year. Revenue for the quarter was $12.9 million, down from $14.6 million a y
Via MarketBeat · August 12, 2026
OptimizeRx Q2 Earnings Call Highlightsmarketbeat.com
OptimizeRx (NASDAQ:OPRX) reported second-quarter fiscal 2026 revenue of $20.5 million, down 30% from $29.2 million a year earlier, while adjusted EBITDA totaled $4.9 million, management said on its earnings call. The company reaffirmed its full-year revenue outlook of $95 million to $100 million and
Via MarketBeat · August 12, 2026
Carlsmed Eyes Growth as Cervical Launch, Medicare Shift Boost Spine Platformmarketbeat.com
Carlsmed (NASDAQ:CARL) outlined its strategy for expanding its personalized spine-surgery platform, citing clinical data, reimbursement changes and a planned cervical product launch as potential drivers of growth during a Bank of America small- and mid-cap virtual event. Chief Executive Officer Mik
Via MarketBeat · August 12, 2026
Marchex Q2 Earnings Call Highlightsmarketbeat.com
Marchex (NASDAQ:MCHX) reported second-quarter revenue of $11 million, up from $10.6 million in the first quarter, as new sales and customer upsells contributed to growth. The company also outlined its post-acquisition strategy following the July 1 closing of its purchase of Archenia, which managemen
Via MarketBeat · August 12, 2026
MaxCyte Q2 Earnings Call Highlightsmarketbeat.com
MaxCyte (NASDAQ:MXCT) reported second-quarter 2026 revenue of $7.3 million, down 15% from $8.5 million a year earlier, as lower license revenue, timing of instrument placements and prior-year processing assembly purchases affected results. Management said the quarter came in ahead of its expectation
Via MarketBeat · August 12, 2026
Nano Nuclear Energy Q3 Earnings Call Highlightsmarketbeat.com
Nano Nuclear Energy (NASDAQ:NNE) said its third-quarter progress centered on advancing the licensing and engineering of its Kronos microreactor, expanding its nuclear fuel-cycle capabilities through acquisitions, and pursuing potential commercial deployments for data centers, industrial users and go
Via MarketBeat · August 12, 2026
Omeros Q2 Earnings Call Highlightsmarketbeat.com
Omeros (NASDAQ:OMER) reported second-quarter net sales of $28.5 million for YARTEMLEA, its newly launched treatment for hematopoietic stem cell transplant-associated thrombotic microangiopathy, or TA-TMA, as the company generated positive operating cash flow and reduced its convertible debt after th
Via MarketBeat · August 12, 2026
Lumexa Imaging Q2 Earnings Call Highlightsmarketbeat.com
Lumexa Imaging (NASDAQ:LMRI) reported second-quarter revenue growth, higher advanced-imaging volumes and a return to profitability, while narrowing its full-year adjusted EBITDA outlook and reiterating revenue and adjusted earnings-per-share guidance. Chief Executive Officer Caitlin Zulla said the
Via MarketBeat · August 12, 2026
Lulu's Fashion Lounge Q2 Earnings Call Highlightsmarketbeat.com
Lulu's Fashion Lounge (NASDAQ:LVLU) reported second-quarter fiscal 2026 revenue of $67.8 million, down 17% from a year earlier, as lower order volume and higher return rates weighed on sales. The company said it continued to prioritize merchandise assortment changes, inventory discipline and operati
Via MarketBeat · August 12, 2026
Liftoff Mobile Q2 Earnings Call Highlightsmarketbeat.com
Liftoff Mobile (NASDAQ:LFTO) reported second-quarter revenue growth and expanded adjusted EBITDA margins in its first earnings call as a public company, citing demand across the app economy, continued machine-learning improvements and activity tied to the FIFA World Cup. Revenue rose 7% sequentiall
Via MarketBeat · August 12, 2026
Jack In The Box Q3 Earnings Call Highlightsmarketbeat.com
Jack In The Box (NASDAQ:JACK) reported a 1.1% decline in third-quarter fiscal 2026 same-store sales, as a drop in transactions more than offset menu price increases. Interim Chief Executive Officer Mark King said the company is focused on improving execution, restaurant quality, customer relevance a
Via MarketBeat · August 12, 2026
Kura Oncology Q2 Earnings Call Highlightsmarketbeat.com
Kura Oncology (NASDAQ:KURA) reported second-quarter net product revenue of $9.1 million from KOMZIFTI, its treatment for relapsed or refractory NPM1-mutated acute myeloid leukemia, as the company said the drug captured a majority share of new patient starts in the menin inhibitor market for that ind
Via MarketBeat · August 12, 2026
Harmonic Q2 Earnings Call Highlightsmarketbeat.com
Harmonic (NASDAQ:HLIT) reported second-quarter 2026 broadband revenue of $133.5 million, up 54% from a year earlier and above its prior guidance range of $115 million to $125 million, as deployment activity expanded among customers outside of its two largest accounts. The company also raised its fu
Via MarketBeat · August 12, 2026
Inovio Pharmaceuticals Q2 Earnings Call Highlightsmarketbeat.com
Inovio Pharmaceuticals (NASDAQ:INO) said the U.S. Food and Drug Administration has completed several key steps in its review of the company’s biologics license application for INO-3107, an investigational treatment for recurrent respiratory papillomatosis, or RRP, while the company continues prepara
Via MarketBeat · August 12, 2026
Fossil Group Q2 Earnings Call Highlightsmarketbeat.com
Fossil Group (NASDAQ:FOSL) reported second-quarter 2026 net sales of $211 million, down 4% from a year earlier but ahead of the company’s expectations as sales trends continued to improve. Chief Executive Officer Franco Fogliato said the results reflected progress in the company’s turnaround plan, w
Via MarketBeat · August 12, 2026
Grocery Outlet Q2 Earnings Call Highlightsmarketbeat.com
Grocery Outlet (NASDAQ:GO) reported second-quarter results that exceeded its outlook as the retailer said efforts to strengthen its opportunistic assortment, sharpen value messaging and improve store execution gained traction. Net sales rose 1% year over year to $1.19 billion for the quarter ended
Via MarketBeat · August 12, 2026
Fortress Biotech Q2 Earnings Call Highlightsmarketbeat.com
Journey Medical reported higher second-quarter revenue and improved profitability, driven by continued prescription growth and improving payer reimbursement for its rosacea treatment Emrosi. Chief Executive Officer Claude Maraoui said the company generated positive EBITDA in the second quarter and
Via MarketBeat · August 12, 2026
CuriosityStream Q2 Earnings Call Highlightsmarketbeat.com
CuriosityStream (NASDAQ:CURI) reported what Chief Executive Officer Clint Stinchcomb described as the strongest quarterly financial performance in the company’s history for the second quarter of 2026, driven by growth in licensing revenue, lower operating expenses and improved margins. Revenue tota
Via MarketBeat · August 12, 2026
Journey Medical Q2 Earnings Call Highlightsmarketbeat.com
Journey Medical (NASDAQ:DERM) reported higher second-quarter revenue and a sharply narrower net loss as sales of its rosacea treatment EMROSI continued to grow, supported by rising prescription volume, broader prescriber adoption and improving payer reimbursement. Total revenue for the second quart
Via MarketBeat · August 12, 2026
Enovix Q2 Earnings Call Highlightsmarketbeat.com
Enovix (NASDAQ:ENVX) reported second-quarter 2026 revenue at the high end of its guidance and highlighted progress in smartphone battery qualification, an initial commercial ramp in smart eyewear, and expanding drone and defense opportunities. Revenue for the quarter was $9 million, up 21% from a y
Via MarketBeat · August 12, 2026
Allot Q2 Earnings Call Highlightsmarketbeat.com
Allot (NASDAQ:ALLT) reported second-quarter 2026 revenue growth, improved profitability and stronger operating cash flow, supported by continued expansion of its Security-as-a-Service, or SECaaS, business and a sharp increase in North American sales. Revenue for the quarter totaled $27.7 million, u
Via MarketBeat · August 12, 2026
A2Z Cust2Mate Solutions Q2 Earnings Call Highlightsmarketbeat.com
A2Z Cust2Mate Solutions (NASDAQ:AZ) reported sequential revenue growth in the second quarter of fiscal 2026 as Smart Cart deliveries increased and its China manufacturing facility began operations. Revenue rose to $5.9 million in the quarter from $3.3 million in the first quarter, while Smart Cart
Via MarketBeat · August 12, 2026
Cerebras Systems Q2 Earnings Call Highlightsmarketbeat.com
Cerebras Systems (NASDAQ:CBRS) reported record second-quarter core revenue and raised its full-year outlook, as the AI infrastructure company said it is expanding data-center capacity, manufacturing output and customer deployments to support anticipated growth beginning in 2027. Chief Executive Off
Via MarketBeat · August 12, 2026
Capstone Energy+ Q1 Earnings Call Highlightsmarketbeat.com
Capstone Energy+ (NASDAQ:CEPL) reported fiscal first-quarter 2027 revenue of $24.9 million for the quarter ended June 30, 2026, down from $27.9 million a year earlier, as lower product shipment volume and reduced rental utilization were partly offset by growth in parts and service revenue. Despite
Via MarketBeat · August 12, 2026
Cisco Systems Q4 Earnings Call Highlightsmarketbeat.com
Cisco Systems (NASDAQ:CSCO) reported record fourth-quarter and fiscal 2026 results, citing broad demand for networking, AI infrastructure, security and collaboration products. The company also issued fiscal 2027 guidance that calls for continued revenue and earnings growth as it pursues what Chief E
Via MarketBeat · August 12, 2026
Alpha and Omega Semiconductor Q4 Earnings Call Highlightsmarketbeat.com
Alpha and Omega Semiconductor (NASDAQ:AOSL) reported fiscal 2026 fourth-quarter revenue above the midpoint of its guidance, as growth in advanced computing and communications helped offset softer demand in traditional PCs and gaming applications. Revenue for the June quarter totaled $170.4 million,
Via MarketBeat · August 12, 2026
Atea Pharmaceuticals Q2 Earnings Call Highlightsmarketbeat.com
Atea Pharmaceuticals (NASDAQ:AVIR) reported positive top-line results from its Phase III C-BEYOND trial of bemnifosbuvir/ruzasvir for chronic hepatitis C virus, saying the study met its primary and secondary endpoints against the standard-of-care regimen sofosbuvir/velpatasvir, marketed as Epclusa.
Via MarketBeat · August 12, 2026
Allogene Therapeutics Q2 Earnings Call Highlightsmarketbeat.com
Allogene Therapeutics (NASDAQ:ALLO) outlined progress across its clinical pipeline during its second-quarter 2026 conference call, highlighting expanded enrollment infrastructure for its pivotal ALPHA3 lymphoma study, recent FDA designations for cema-cel, published renal cell carcinoma data for ALLO
Via MarketBeat · August 12, 2026
Pason Systems Q2 Earnings Call Highlightsmarketbeat.com
Pason Systems (TSE:PSI) reported higher second-quarter revenue, adjusted EBITDA and net income as improving North American drilling activity and higher product adoption supported its core drilling business, while its completions operation continued to grow revenue despite lower industry frac activit
Via MarketBeat · August 12, 2026
Questerre Energy Q2 Earnings Call Highlightsmarketbeat.com
Questerre Energy (TSE:QEC) said its newly acquired Brazilian operation generated a record quarterly profit for PX Energy and continued to produce positive cash flow, while the company advanced testing of its oil-shale refining technology and outlined developments related to its Quebec natural-gas as
Via MarketBeat · August 12, 2026
Sylogist Q2 Earnings Call Highlightsmarketbeat.com
Sylogist (TSE:SYZ) reported second-quarter fiscal 2026 results that showed continued growth in SaaS revenue and annual recurring revenue, while total revenue declined as project services and hardware revenue fell. Management said it is focusing on execution, customer experience, product development
Via MarketBeat · August 12, 2026
Biodesix Sees Nodify Growth, Reaffirms Revenue Outlook at Canaccord Conferencemarketbeat.com
Biodesix (NASDAQ:BDSX) said its commercial expansion, broader primary care outreach and recently published clinical data supporting use of its Nodify CDT test in smaller lung nodules are among the principal drivers of its growth strategy. Speaking at the Canaccord Genuity Growth Conference, Chief E
Via MarketBeat · August 12, 2026
HLS Therapeutics Q2 Earnings Call Highlightsmarketbeat.com
HLS Therapeutics (TSE:HLS) reported second-quarter fiscal 2026 revenue growth as its cardiovascular portfolio expanded 25% year over year, led by continued gains for Vascepa and the first full quarter of sales for newly launched NILEMDO. Total revenue for the quarter ended June 30 was $14.7 million
Via MarketBeat · August 12, 2026
Maple Leaf Foods Q2 Earnings Call Highlightsmarketbeat.com
Maple Leaf Foods (TSE:MFI) reported second-quarter revenue growth and higher profitability, while reaffirming its full-year 2026 outlook as poultry momentum, pricing actions and operating efficiencies offset weaker prepared-food volumes. Second-quarter sales rose 1.6% year over year to CAD 1.02 bil
Via MarketBeat · August 12, 2026
Metro Q3 Earnings Call Highlightsmarketbeat.com
Metro (TSE:MRU) reported lower third-quarter earnings as an ongoing strike at its Laval, Quebec, produce distribution center weighed on sales, margins and operating costs, while the grocery and pharmacy retailer outlined network changes intended to improve longer-term returns. For the quarter ended
Via MarketBeat · August 12, 2026
Peyto Exploration & Development Q2 Earnings Call Highlightsmarketbeat.com
Peyto Exploration & Development (TSE:PEY) said its second-quarter operations were affected by wet spring and early-summer conditions that reduced field activity, but production remained broadly consistent with the prior quarter due to a strong first-quarter drilling program. President and Chief Exe
Via MarketBeat · August 12, 2026
Exchange Income Q2 Earnings Call Highlightsmarketbeat.com
Exchange Income (TSE:EIF) said its second-quarter performance set records across key financial measures and prompted the company to raise its 2026 adjusted EBITDA guidance to between C$890 million and C$920 million. Chief Executive Officer Mike Pyle said the company recorded second-quarter highs in
Via MarketBeat · August 12, 2026
Hydro One Q2 Earnings Call Highlightsmarketbeat.com
Hydro One (TSE:H) reported higher second-quarter earnings as approved 2026 rates, increased electricity demand and customer growth lifted revenue, while the company outlined a growing pipeline of transmission investments and plans to file its next joint rate application in October. Net income attri
Via MarketBeat · August 12, 2026
AudioEye Targets Defense, Automotive Growth With Software-Defined LiDARmarketbeat.com
AEye executives outlined the company’s strategy to expand its software-defined LiDAR technology across automotive, defense, security and other “physical AI” applications, emphasizing long-range sensing, manufacturing flexibility and a capital-light business model during a J.P. Morgan conference pres
Via MarketBeat · August 12, 2026
Constellation Software Q2 Earnings Call Highlightsmarketbeat.com
Constellation Software (TSE:CSU) used its second-quarter conference call to outline its approach to artificial intelligence, vertical-market organization and acquisitions, while executives addressed recent organic-growth pressure tied to several acquired businesses and comparison effects. President
Via MarketBeat · August 12, 2026
Cipher Pharmaceuticals Q2 Earnings Call Highlightsmarketbeat.com
Cipher Pharmaceuticals (TSE:CPH) reported lower second-quarter revenue and earnings as sales of its U.S. Natroba treatment declined, while its Canadian Epuris product posted growth and market-share gains. Management said the company remains focused on expanding commercial channels for Natroba, widen
Via MarketBeat · August 12, 2026
Avino Silver & Gold Mines Q2 Earnings Call Highlightsmarketbeat.com
Avino Silver & Gold Mines (TSE:ASM) reported second-quarter 2026 revenue of $26.8 million and net income of $10.9 million, or $0.06 per diluted share, as the company increased development production at its La Preciosa project and continued to advance its multi-asset growth strategy in Mexico. Chief
Via MarketBeat · August 12, 2026
BTB Real Estate Investment Trust Q2 Earnings Call Highlightsmarketbeat.com
BTB Real Estate Investment Trust (TSE:BTB.UN) reported higher second-quarter rental revenue and operating income as it continued to shift its portfolio toward industrial assets while pursuing sales of office properties. President and Chief Executive Officer Michel Léonard said the trust remained ac
Via MarketBeat · August 12, 2026
Computer Modelling Group Q1 Earnings Call Highlightsmarketbeat.com
Computer Modelling Group (TSE:CMG) said first-quarter fiscal 2027 revenue declined as growth from recent acquisitions was outweighed by lower organic revenue and a planned reduction in non-core professional services work, while management reaffirmed its full-year outlook for stable organic recurring
Via MarketBeat · August 12, 2026
Air Canada Q2 Earnings Call Highlightsmarketbeat.com
Air Canada (TSE:AC) reported second-quarter 2026 adjusted EBITDA of C$719 million, at the upper end of its guidance range, as record revenue and stronger unit revenue helped offset higher fuel costs. The airline said adjusted EBITDA margin was 11.5%. Operating revenue rose 11% from a year earlier t
Via MarketBeat · August 12, 2026
Andean Precious Metals Q2 Earnings Call Highlightsmarketbeat.com
Andean Precious Metals (TSE:APM) reported second-quarter results shaped by a decision to defer sales of a portion of its gold and silver production, while management said operating performance remained strong and reaffirmed its full-year production, cost and margin guidance. The company ended the q
Via MarketBeat · August 12, 2026